This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment. The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field. Key Features:Details the epidemiology and pathophysiology of lung cancer, covering disease prevalence, risk factors, and cellular mechanismsExamines the diagnostic capabilities of nanotechnology, emphasizing the use of nanoparticles in early detection and imagingExplores the therapeutic potential of various nanomaterials, such as liposomes, dendrimers, and quantum dots, for enhanced drug delivery and treatmentHighlights theranostic nanoparticles, combining diagnostic and therapeutic functions for personalized cancer careReviews clinical trials and emerging trends, providing insights into the future of nanotechnology-based lung cancer therapiesThe book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.
